Rice psychologists named APS Fellows for advancing research with real-world impact
Two Rice researchers recently named fellows of the Association for Psychological Science, one of the field’s leading international organizations.
In collaboration with the Houston Health Department, the Rice360 Institute for Global Health Technologies recently hosted a two-part Mobile Stroke Unit Advocacy Hack-a-thon, inviting students to help solve one of the most pressing challenges facing this innovative technology.
Brains in society: De Lange Conference explores how neuroscience is shaping the future
Neuroscientists, artists, educators and policymakers gathered at Rice for the De Lange Conference to explore questions at the center of everyday life: how the brain works and what that means for society.
From climate storytelling to AI innovation: Rice researchers take on global challenges at SXSW
At this year’s South by Southwest (SXSW) conference in Austin, Rice researchers explored how to close that gap, whether by rethinking how climate change is communicated or by accelerating scientific discovery through artificial intelligence.
Rice's Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over extended periods.
CRISPR-based technique unlocks healing power of mitochondria for heart failure therapy
Rice researchers and collaborators induced heart cells to increase mitochondria production to optimal levels, opening a path toward a new therapy for heart failure.
A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind regenerative treatment aimed at restoring damaged lymphatic vessels and potentially curing lymphedema, a condition that affects more than 10 million Americans.
Rice’s SynthX Center leads up to $18M effort to transform lymphatic imaging
Rice's SynthX Center is leading a new effort to improve how doctors detect and diagnose lymphatic diseases.
Platform to map living brain noninvasively takes next big step
A technology designed to read gene activity in the brain from a simple blood test has now cleared a major translational hurdle.
Day in the life: Health sciences senior follows research toward clinical psychology
Isabella Bourtin balances GRE prep, lab work and upper-level courses as she pivots from pre-med ambitions toward a future in clinical psychology.
More precise DNA base editing could improve treatment for cystic fibrosis
Researchers at Rice and collaborators have refined a DNA base-editing technology to make it more precise, a step that could improve prospects for treating some patients with cystic fibrosis.
New Rice-led perspective charts path to next-generation water and energy membranes
A new invited perspective in Nature Water, led by Rice researchers and international collaborators, discusses the future of membrane science.
Noninvasive paths to complex brain science: Rice bioengineer named Sloan Research Fellow
Rice bioengineer Jerzy Szablowski has been named a 2026 Alfred P. Sloan Research Fellow in chemistry, one of the most competitive honors for early career scientists in the U.S. and Canada.
Metabolic clues emerge from new molecular map of Alzheimer’s
Rice scientists have developed the first complete, label-free molecular atlas of the Alzheimer’s brain in an animal model.
Rice360 and African universities inspiring new generation of inventors and global health innovators
When the Rice360 Institute for Global Health Technologies launched the first design studios in partner universities across Africa during Phase 1 of the NEST360 initiative, the vision was clear: create sustainable, university-based ecosystems that empower students to design, prototype and commercialize lifesaving technologies inspired by real needs in their own communities.